Anbio Biotechnology: current_assets
| Value | {"amount": 30242859, "concept": "us-gaap:AssetsCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2025-12-31) |
| Status | current |
| Entity | Anbio Biotechnology |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d0a18ed8-f93c-4a9c-b4ff-c98d0855c338
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001185185-26-001294Retrieved: 2026-08-19T19:02:33.643442+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001982708/current-assets/2025-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d0a18ed8-f93c-4a9c-b4ff-c98d0855c338
History
- no predecessors — first report